https://www.ophthalmologytimes.com/view/patient-case-1-59-year-old-male-with-dme 2022-08-18 0.50 https://www.ophthalmologytimes.com/view/link-discovered-between-retina-and-brain-structures-in-patients-with-high-genetic-risk-of-alzheimer-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/research-aims-to-regenerate-photoreceptors-cells-via-stem-cell-based-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/gene-fragments-revealed-play-crucial-role-in-retinal-development-and-vision 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/computational-platform-identifies-viral-vectors-for-efficacious-gene-therapy-delivery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/first-patient-dosed-in-phase-2-davio-trial-for-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/research-reveals-genetic-signatures-of-amd-may-lead-to-improved-diagnosis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/foundation-fighting-blindness-building-a-toolbox-of-therapies-for-dry-amd-inherited-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retrospective-study-compares-ai-teleophthalmology-diagnosis-for-diabetic-retinopathy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fighting-pigmentary-retinopathy-by-inhibiting-photoreceptor-death 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/phase-4-paladin-results-confirm-durability-of-fluocinolone-acetonide-intravitreal-implant-for-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/loss-of-youth-protein-may-drive-aging-in-the-eye-nei-study-finds 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-human-cell-line-for-studying-blinding-eye-disorders-discovered-by-lsu-health-sciences-center 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/faricimab-for-dme-personalized-treatment-interval-dosing-maintains-visual-acuity-reduces-treatment-burden 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/first-patient-dosed-in-starlight-phase-2-clinical-trial-of-optogenetic-gene-therapy-for-stargardt-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/assessing-changes-in-retina-over-time-following-uncomplicated-cataract-extraction 2022-07-21 0.50 https://www.ophthalmologytimes.com/view/national-poll-indicates-only-half-of-parents-recognize-risk-of-screen-time-on-children-s-eye-health 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/diabetic-retinopathy-eye-drop-phase-1b-clinical-results-show-promise 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-introduces-campaign-to-increase-awareness-of-retinal-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/quicker-time-to-surgery-affects-va-outcomes-in-macula-on-rhegmatogenous-retinal-detachments 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-grants-priority-review-for-intravitreal-pegcetacoplan-bla-from-apellis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/giant-retinal-tear-related-detachments-pediatric-eyes-repair-better-after-vitrectomy-with-scleral-buckling-adults-only-need-vitrectomy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-2022-recap-significant-strides-in-dme-amd-discussed-among-retina-specialists 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/investigating-surgical-approaches-for-progressive-retinal-detachments-secondary-to-retinoschisis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/kalahari-study-phase-2-early-results-indicate-alternative-treatment-pathway-for-patients-with-dme-is-effective-durable 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/elevated-albumin-to-creatinine-ratio-associated-with-central-subfield-thickness-fluctuations-in-patients-with-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/rgx-314-demonstrates-drss-improvements-in-patients-with-dme-npdr 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-tool-emerges-for-predicting-the-risk-of-vision-loss-from-diabetic-retinopathy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/metformin-may-have-a-protective-effect-against-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/davio-trial-12-month-results-show-favorable-safety-profile-reduced-treatment-burden-in-patients-with-namd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/tower-study-a-new-index-to-measure-retinal-fluid-fluctuations-in-the-retina-in-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/peachtree-post-hoc-analysis-significant-reduction-of-macular-edema-low-rate-of-rescue-in-patients-with-chronic-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pediatric-retinal-detachment-surgery-in-the-us-primary-scleral-buckling-achieved-best-visual-acuity 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dme-faricimab-remains-durable-effective-in-2-year-results-of-yosemite-and-rhine-trials 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/truckee-study-real-world-safety-and-efficacy-of-faricimab-for-neovascular-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/delving-into-the-24-week-results-for-ubx1325-for-the-treatment-of-chronic-dme-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/the-relationship-between-outer-retinal-integrity-subretinal-fluid-may-affect-treatment-outcomes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/miniature-telescope-in-dry-amd-surgical-implantation-improves-vision-for-patients-with-late-stage-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-results-will-you-be-attending-asrs-2022- 2022-07-11 0.50 https://www.ophthalmologytimes.com/view/exploring-cryopreserved-amniotic-membrane-following-intravitreal-injection 2022-07-08 0.50 https://www.ophthalmologytimes.com/view/preventing-retinal-scarring-with-novel-thermogel-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/protein-levels-in-eye-fluid-may-predict-need-for-lifelong-therapy-for-macular-degeneration 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/gene-therapy-where-the-action-is-for-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aaviate-gene-therapy-via-suprachoroidal-drug-delivery-may-lower-treatment-burden-for-patients-with-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-all-things-retina-in-the-big-apple 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/evaluating-effect-of-central-subfield-thickness-volatility-on-visual-acuity-in-clinical-trials-for-namd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retinal-cells-may-house-ebola-other-viruses 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-will-you-be-attending-asrs- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/copernicus-and-galileo-trials-effect-of-time-since-diagnosis-on-bcva-outcomes-in-crvo 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/phase-3-archway-end-of-trial-results-port-delivery-system-is-noninferior-to-monthly-ranibizumab 2022-06-29 0.50 https://www.ophthalmologytimes.com/view/new-data-from-phase-1-2-clinical-study-of-gene-therapy-for-patients-with-x-linked-retinitis-pigmentosa-announced-by-meiragtx 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/morphologic-features-of-vitreous-cortex-hyalocyte-captured-with-oct 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/survey-retina-specialists-see-need-for-alternative-treatments-for-macular-edema-associated-with-noninfectious-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/improvement-in-vision-in-intermediate-dry-amd-demonstrated-in-lightsite-iii-trial-data 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/molecular-mechanism-discovered-to-cause-photoreceptor-degeneration-in-retinitis-pigmentosa 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/impressions-and-take-away-points-from-patient-case-2 2022-07-01 0.50 https://www.ophthalmologytimes.com/view/patient-case-2-52-year-old-patient-with-recurrent-uveitis 2022-07-01 0.50 https://www.ophthalmologytimes.com/view/impressions-and-take-away-points-from-patient-case-1 2022-07-01 0.50 https://www.ophthalmologytimes.com/view/patient-case-1-65-year-old-patient-with-uveitis 2022-07-01 0.50 https://www.ophthalmologytimes.com/view/expanding-the-therapeutic-arsenal-for-noninfectious-uveitis-uveitic-macular-edema 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/phase-3-investigation-of-opt-302-combination-therapy-assess-superiority-in-mean-bcva-over-anti-vegf-a-monotherapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/permanent-j-code-granted-for-triamcinolone-acetonide-injectable-suspension-from-bausch-lomb 2022-06-22 0.50 https://www.ophthalmologytimes.com/view/pediatric-vision-impairment-associated-with-increased-risk-of-depression-anxiety 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/practice-perspective-academic-retina 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/addressing-the-urgent-unmet-need-among-patients-with-geographic-atrophy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-genetic-eye-disease-discovered-by-nih-researchers 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/case-2-impressions-and-clinical-insights 2022-06-16 0.50 https://www.ophthalmologytimes.com/view/case-2-a-52-year-old-with-recurrent-uveitis 2022-06-16 0.50 https://www.ophthalmologytimes.com/view/case-1-impressions-and-clinical-insights 2022-06-16 0.50 https://www.ophthalmologytimes.com/view/case-1-a-62-year-old-patient-with-uveitis 2022-06-16 0.50 https://www.ophthalmologytimes.com/view/pearls-for-recognizing-and-treating-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/perspectives-on-intravenous-bevacizumab-repackaged-for-intravitreal-use 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/measuring-retinal-blood-flow-biomarkers-using-oct-doppler 2022-06-13 0.50 https://www.ophthalmologytimes.com/view/functional-microglia-derived-from-human-pluripotent-stem-cells-in-retinal-organoids 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dietary-supplements-beneficial-for-slowing-amd-confirmed-by-nih 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-approach-to-oct-image-biomedical-samples-at-higher-contrast-resolution 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/hypersonic-vitrectomy-novel-technology-for-vitreous-removal 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/key-discovery-humanin-g-reduces-protein-levels-of-inflammation-markers-associated-with-amd 2022-06-07 0.50 https://www.ophthalmologytimes.com/view/carl-regillo-md-outlines-latest-results-of-ksi-301-clinical-trial 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/yosemite-and-rhine-trials-yield-durability-retinal-fluid-reduction-dme-resolution-with-faricimab 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/first-patient-dosed-in-the-phase-1-clinical-trial-of-am712-for-neovascular-amd 2022-06-01 0.50 https://www.ophthalmologytimes.com/view/managing-the-treatment-of-patients-with-endophthalmitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/first-fda-approved-ophthalmic-biosimilar-ranibizumab-nuna-launches-in-the-united-states 2022-06-14 0.50 https://www.ophthalmologytimes.com/view/ranibizumab-and-aflibercept-safe-for-treating-dme-according-to-registry-data 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/brolucizumab-dbll-6-mg-receives-fda-approval-for-the-treatment-of-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-drug-application-filed-for-pegcetacoplan-for-the-treatment-of-geographic-atrophy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/additional-information-requested-for-bla-for-ons-5010-outlook-to-resubmit-by-september 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/at-home-subcutaneous-anti-vegf-injection-for-wet-amd-dme-is-safe-effective-in-phase-1-trial 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/finding-uveitis-in-the-clinic-imaging-tests-to-catch-signs-and-symptoms 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/results-of-phase-2-reclaim-2-study-of-elamipretide-for-dry-amd-announced-by-stealth-biotherapeutics 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-aims-to-identify-cell-types-specific-genes-in-treating-primary-open-angle-glaucoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/using-machine-learning-to-predict-treatment-options-for-patients-with-namd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retinal-cell-map-sheds-light-on-tissue-targeted-by-amd-may-advance-precise-therapies-for-disease 2022-05-18 0.50 https://www.ophthalmologytimes.com/view/decreasing-vision-loss-rates-with-modular-digital-vision-screening-platform 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/investigating-the-efficacy-of-targeting-the-ang-tie2-pathway-with-faricimab 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/patients-recognize-role-of-artificial-intelligence-in-diagnosis-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/amblyopia-affects-binocular-vision-research-suggests 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/maculogix-crosses-threshold-of-1-million-dark-adaption-tests 2022-05-18 0.50 https://www.ophthalmologytimes.com/view/eyp-1901-introduces-treat-to-maintain-paradigm-for-anti-vegf-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/cell-therapy-trial-may-lead-to-treatment-for-dry-amd-geographic-atrophy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/tissue-preservation-should-be-considered-as-endpoint-for-geographic-atrophy-therapies 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-applauds-congress-for-passage-of-key-milestone-for-prior-authorization-reform-bill 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/derby-and-oaks-18-month-data-shows-continuous-reduction-in-foveal-extrafoveal-lesion-growth-in-eyes-with-ga 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-results-are-you-attending-retina-world-congress-2022- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/phase-3-peachtree-azalea-integrated-study-results-bcva-gains-cst-reduction-associated-with-suprachoirodal-injection 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/capturing-the-treatment-burden-of-diabetic-retinopathy-with-novel-pro-instrument 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/phase-2-integral-trial-thr-689-fails-to-meet-primary-endpoints-in-eyes-with-dme-will-not-advance 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/novel-oculomotor-characteristics-of-achromatopsia 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/insights-on-treating-patients-with-macular-edema-associated-with-noninfectious-uveitis 2022-05-09 0.50 https://www.ophthalmologytimes.com/view/diabetic-retinopathy-s-effect-on-early-visual-outcomes-after-cataract-surgery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/phase-1-safety-data-for-subcutaneous-anti-vegf-candidate-for-wet-amd-dme-presented-at-arvo 2022-05-06 0.50 https://www.ophthalmologytimes.com/view/amd-remote-monitoring-improves-outcomes-for-patients-retrospective-study-shows 2022-05-05 0.50 https://www.ophthalmologytimes.com/view/arvo-2022-recap-a-review-of-data-and-innovation-at-the-annual-meeting 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/2-year-results-of-yosemite-and-rhine-faricimab-remains-noninferior-to-aflibercept-with-extended-dosing-schedule 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-prognostic-test-emerges-as-strong-predictor-of-metastasis-of-uveal-melanoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/myopia-control-investigating-spectacle-lenses-and-their-effect-on-axial-length-in-pilot-study 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/thr-687-protects-diabetic-rats-from-macular-edema-hallmarks 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/from-covid-delays-to-staff-shortages-how-to-face-the-challenges-of-clinical-research 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/decreasing-risk-of-ocular-surface-damage-by-taping-masks-to-skin-during-the-covid-19-pandemic 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/long-term-effects-of-anti-vegf-injections-on-renal-function-examined-in-study 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-examines-relationship-between-dry-eye-disease-and-high-myopia-in-teenagers 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/a-discourse-in-clinical-study-timelines-and-the-need-for-acceleration-in-retina-research 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/high-drug-levels-delivered-to-retinal-tissue-via-axitnib-intravitreal-implant-for-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/widespread-brain-changes-linked-to-chronic-iop-elevation-affects-cerebrovascular-reactivity-in-murine-visual-cortex 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/opt-302-combination-therapy-with-ranibizumab-for-pcv-shows-va-gains-anatomic-improvements-in-phase-2b-trial 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/increased-choroidal-central-corneal-thickness-in-children-linked-to-short-periods-of-intensive-outdoor-activity 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-are-you-attending-retina-world-congress-2022- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-results-will-you-be-attending-arvo-2022- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/taking-visual-field-analysis-to-a-higher-level-with-the-icare-compass-automated-perimeter 2022-05-10 0.50 https://www.ophthalmologytimes.com/view/long-lasting-vision-improvement-linked-to-treatment-for-retinal-vein-occlusion 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ascrs-review-for-retina-specialists 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/geographic-atrophy-survey-reveals-heavy-emotional-burden-decreased-independence-for-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/digital-health-care-in-ophthalmology-opportunities-and-limitations-for-retina-specialists 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/diving-into-the-relationship-between-amblyopia-and-fixation-eye-movements 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/uci-investigators-reveal-data-that-will-usher-in-a-new-era-of-drug-discovery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-are-you-planning-to-attend-arvo-2022- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ultrasound-stimulates-blind-retina-suggests-hope-for-noninvasive-therapy-for-vision-loss 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/increased-incidence-of-retinal-vascular-occlusions-after-covid-19-diagnosis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/illuminate-trial-updates-additional-analyses-required-for-sepofarsen-for-lca10 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/this-week-in-retina-april-8-14 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/bariatric-surgery-may-reduce-diabetic-retinopathy-risk 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/first-pediatric-patient-dosed-in-lca10-gene-editing-clinical-trial 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/uci-study-cites-base-editing-as-a-durable-one-time-treatment-for-inherited-retinal-degeneration 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/trial-to-study-treatment-of-dme-in-underrepresented-patients-begins 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/-focus-on-child-eye-health-presented-by-international-agency-for-the-prevention-of-blindness 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/artificial-retinal-device-increases-edge-of-contrast-mimics-human-optical-illusions 2022-04-06 0.50 https://www.ophthalmologytimes.com/view/outcomes-of-anti-vegf-therapy-for-retinal-diseases-altered-by-covid-19-lockdown 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/brolucizumab-6-mg-approved-by-european-commission-for-treatment-of-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/racial-disparities-in-diabetic-eye-care 2022-04-01 0.50 https://www.ophthalmologytimes.com/view/gene-required-for-survival-of-retinal-ganglion-cells-identified-by-japanese-investigators 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/uncovering-germline-mutation-risk-in-children-with-unilateral-retinoblastoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/first-dose-administered-in-phase-1-2-clinical-trial-for-gene-therapy-candidate-ocu400-for-inherited-retinal-degeneration 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/uplizna-safe-effective-for-patients-with-neuromyelitis-optica-spectrum-disorder 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/bausch-lomb-announces-xipere-commercial-launch-in-us 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/outlook-therapeutics-submits-bla-for-ophthalmic-bevacizumab-ons-5010-as-treatment-for-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ultra-widefield-imaging-a-critical-step-in-uveitis-diagnosis-and-management 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/less-may-be-more-for-intravitreal-bevacizumab-in-retinopathy-of-prematurity 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/suprachoroidal-injection-successfully-delivers-drug-to-the-macula-posterior-segment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/adapting-the-inverted-internal-limiting-membrane-flap-technique-in-very-large-macular-hole-surgery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/lightsite-iii-clinical-trial-update-lumithera-shares-data-for-dry-amd-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/drug-designed-to-decrease-alcohol-dependence-may-save-vision-for-patients-with-rp-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retina-may-be-a-potential-biomarker-for-reduced-brain-matter-according-to-new-study 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/decreased-retinal-vascular-density-linked-to-moderate-to-severe-covid-19-pneumonia 2022-03-23 0.50 https://www.ophthalmologytimes.com/view/intensive-multimodal-therapy-found-to-be-safe-effective-for-orbital-retinoblastoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pds-ushers-in-a-new-era-in-treatment-of-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/intravitreal-injections-for-retinopathy-of-prematurity-prove-safe-effective-in-many-cases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/phase-2-clinical-trial-of-adx-2191-for-retinitis-pigmentosa-begins 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/foundation-fighting-blindness-informeddna-screening-patients-for-pivotal-clinical-trials-for-usher-syndrome-and-retinitis-pigmentosa-clinical-trials 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/controlling-intraocular-inflammation-associated-with-brolucizumab 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/monitoring-patients-for-neovascular-amd-in-the-office-and-at-home 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/apellis-unveils-18-month-results-from-phase-3-oaks-and-derby-studies 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/addressing-the-concerns-of-using-repackaged-iv-bevacizumab-in-wet-amd-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/emerging-treatments-for-advanced-dry-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/reshaping-retina-treatment-with-faricimab 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-finds-that-sound-stimulates-blind-retina-to-transmit-signals-to-the-brain 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/former-ucla-faculty-member-donates-10-million-for-ocular-genetics-research 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/hospital-bombing-in-ukraine-includes-ophthalmology-department 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/healthy-circadian-rhythm-may-protect-aging-eyes-from-retinal-degeneration 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/first-robot-assisted-ab-interno-gonio-intervention-paves-the-way-for-robotic-eye-surgery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/from-intravitreal-injections-to-gene-therapy-new-amd-treatments-are-on-the-horizon 2022-03-09 0.50 https://www.ophthalmologytimes.com/view/world-glaucoma-week-a-retina-specialist-s-guide-to-recent-innovations-in-glaucoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sigma-1-receptor-may-protect-retinal-and-brain-cells-impacted-by-glaucoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/highlighting-major-advances-in-retinal-diagnostics-therapeutics-presented-at-angiogenesis-2022 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/celebrating-40-years-of-innovation-from-orbis-international 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/5-tips-for-contract-negotiations-for-young-ophthalmologists 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/march-is-declared-to-be-workplace-eye-wellness-month-per-prevent-blindness 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/rare-disease-day-celebrating-the-progress-of-treating-inherited-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/phase-2b-3-results-for-namd-candidate-ksi-301-revealed-by-kodiak-sciences 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/first-successful-implantation-of-wireless-visual-prosthesis-brain-implant-completed 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/covid-19-linked-to-retina-concerns-comparable-to-purtscher-retinopathy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/paladin-3-year-results-fluocinolone-acetonide-intravitreal-implant-improves-visual-acuity-cst 2022-02-24 0.50 https://www.ophthalmologytimes.com/view/conquering-the-crisis-of-diabetes-among-black-americans 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/monte-carlo-simulation-indicates-positive-outcomes-for-anti-vegf-therapy-in-severe-npdr 2022-02-21 0.50 https://www.ophthalmologytimes.com/view/inebilizumab-cdon-reduces-neuromyelitis-optica-spectrum-disorder-attack-severity 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/complement-targeted-gene-therapies-for-treatment-of-ga-other-ocular-diseases-licensed-by-kriya-therapeutics 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-grants-ind-clearance-for-affamed-s-am712-to-treat-retinal-vascular-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-programs-available-for-residents-at-the-stein-eye-institute 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/last-patient-in-stealth-biotherapeutics-phase-2-geographic-atrophy-clinical-trial-completes-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/alzheimer-disease-the-retina-may-predict-cognitive-changes-in-middle-age 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/candela-phase-2-results-indicate-benefits-in-high-dose-aflibercept-for-wet-amd 2022-02-15 0.50 https://www.ophthalmologytimes.com/view/ubx1325-phase-1-study-data-revealed-at-angiogenesis 2022-02-15 0.50 https://www.ophthalmologytimes.com/view/angiogenesis-2022-study-results-reveal-novel-options-for-geographic-atrophy-diabetic-eye-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/results-for-ai-algorithm-for-autonomous-screening-detection-of-diabetic-retinopathy-reported-by-aeye-health 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/rna-therapy-may-halt-the-progression-of-stargardt-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/stargardt-research-explores-rna-gene-therapy-options 2022-02-09 0.50 https://www.ophthalmologytimes.com/view/100-week-results-of-kestrel-kite-push-brolucizumab-toward-fda-approval 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/faricimab-safe-durable-treatment-for-dme-over-the-long-term 2022-02-12 0.50 https://www.ophthalmologytimes.com/view/high-dose-of-thr-149-delivers-bcva-increase-stable-cst-in-kalahari-study 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/kalahari-study-finds-thr-149-to-be-safe-well-tolerated-as-treatment-for-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pds-maintains-visual-anatomic-benefits-over-long-term-in-portal-extension-trial 2022-02-12 0.50 https://www.ophthalmologytimes.com/view/detecting-diabetic-retinopathy-with-deep-learning-and-ultra-widefield-scanning-laser-ophthalmoscope-images 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/positive-results-from-davio-trial-investigating-eyp-1901-for-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/staying-at-the-top-optimizing-clinical-care-and-practice-efficiency-with-multimodal-triton-imaging 2022-02-16 0.50 https://www.ophthalmologytimes.com/view/choriocapillaris-atrophy-linked-with-neovascular-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/growth-of-ga-lesions-slowed-by-avacincaptad-pegol-in-clinical-trial 2022-02-11 0.50 https://www.ophthalmologytimes.com/view/focus-clinical-trial-cfi-supplementing-gene-therapy-in-geographic-atrophy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/subretinal-implant-found-to-be-safe-well-tolerated-in-patients-with-advanced-dry-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/connexin-43-blockers-show-promise-for-treatment-of-diabetic-retinopathy-amd 2022-02-07 0.50 https://www.ophthalmologytimes.com/view/initiation-of-inflammatory-cascade-inhibited-by-once-daily-oral-dose-of-xiflam 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/updates-from-angiogenesis-2022 2022-03-03 0.50 https://www.ophthalmologytimes.com/view/stem-cell-derived-retinal-implant-shows-long-term-viability-in-new-data-from-usc-investigators 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-grants-fast-track-designation-to-ngm-bio-s-ngm621 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/vivid-vista-data-study-baseline-factors-affect-dme-resolution 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/cleveland-eye-bank-foundation-virtual-symposium-features-research-from-top-ohio-institutions 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/spect-medarrive-offer-retinal-screening-options-to-vulnerable-patients 2022-02-02 0.50 https://www.ophthalmologytimes.com/view/prevent-blindness-bausch-lomb-honor-amd-awareness-month-with-educational-campaign 2022-02-02 0.50 https://www.ophthalmologytimes.com/view/fda-approves-generic-solution-of-cyclosporine-ophthalmic-emulsion-for-dry-eye 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-investigates-drug-metabolism-and-distribution-in-the-eye 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/usc-launches-center-for-neuronal-longevity-to-address-gaps-in-neurodegenerative-disease-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/foto-tia-study-retinal-microvascular-changes-may-not-predict-future-ischemic-events 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-results-agtc-501-gene-therapy-shows-vision-gains-for-x-linked-rp 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/vision-loss-retinal-changes-in-stargardt-disease-classified-by-nih-study 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dried-goji-berries-may-provide-protection-against-amd-investigators-report 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/video-game-software-created-for-amd-research-uses-oct-imaging-in-gameplay 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dr-mali-discusses-what-faricimab-fda-approval-means-to-retina-specialists 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-approves-faricimab-for-treatment-of-wet-amd-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-grants-clearance-to-ind-for-mco-010-gene-therapy-in-stargardt-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/up-to-30-of-patients-with-wet-amd-can-safely-stop-eye-injections-study-finds 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/faricimab-improved-and-maintained-vision-for-patients-with-wet-amd-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/bascom-palmer-celebrates-60th-anniversary 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/program-for-angiogenesis-2022-ignites-excitement-in-ophthalmologists 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/novel-deep-learning-tool-shows-promise-in-classifying-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/smart-harness-alerts-visually-impaired-people-to-obstacles-while-walking 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/jason-menzo-named-foundation-fighting-blindness-president-coo 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/difference-in-retinal-age-and-real-age-linked-to-increased-death-risk 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ophthalmic-bevacizumab-effectively-treats-wet-macular-degeneration-norse-two-concludes 2022-01-20 0.50 https://www.ophthalmologytimes.com/view/managing-dme-and-increasing-vision-effectively-with-intravitreal-triamcinolone 2022-01-14 0.50 https://www.ophthalmologytimes.com/view/national-eye-institute-grants-funding-to-wvu-to-study-the-mechanism-of-retinal-degeneration 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/staying-at-the-top-empowering-providers-with-the-multimodal-maestro2 2022-01-25 0.50 https://www.ophthalmologytimes.com/view/regenxbio-announces-second-pivotal-trial-ascent-in-rgx-314-clinical-program 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pupillary-sizes-differ-in-active-and-resolved-covid-19-cases-study-finds 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/inserting-intravitreal-dexamethasone-implants-in-vitrectomized-vs-non-vitrectomized-eyes 2022-01-21 0.50 https://www.ophthalmologytimes.com/view/diagnosing-parkinson-s-disease-aided-by-oct-octa-ocular-biomarkers 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/investigating-the-quality-of-real-world-evidence-in-retinal-disease 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/meeting-the-need-of-persistent-long-covid-19-symptoms 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dr-mali-s-top-5-predictions-for-ophthalmology-in-2022 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/unraveling-burdens-of-x-linked-retinitis-pigmentosa 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fluctuating-central-subfield-thickness-in-dme-may-be-a-predictor-of-worse-va 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/research-giants-team-up-to-investigate-effective-gene-therapies-for-rare-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/biosimilars-what-clinicians-should-know 2022-03-04 0.50 https://www.ophthalmologytimes.com/view/using-the-iris-registry-to-analyze-ancillary-testing-patterns-on-a-per-patient-basis 2021-12-21 0.50 https://www.ophthalmologytimes.com/view/discovery-links-lupus-and-macular-degeneration 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sustained-drug-delivery-in-ophthalmology 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/covid-19-pandemic-highlights-the-power-of-electronic-health-records 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/searching-for-durable-therapies-for-diabetic-macular-edema-amid-the-pandemic 2021-12-09 0.50 https://www.ophthalmologytimes.com/view/imprimisrx-and-eyepoint-pharmaceuticals-expand-commercial-alliance-for-dexycu 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2021-reinvigorates-ophthalmologists-for-2022 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/2022-is-year-of-children-s-vision-as-declared-by-prevent-blindness 2021-12-22 0.50 https://www.ophthalmologytimes.com/view/phase-3-of-kestrel-study-novartis-announces-positive-results-for-beovu-for-treatment-of-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/clinical-implications-of-port-delivery-system-in-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/telemedicine-enhanced-by-robotically-aligned-oct 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/parkinson-disease-diagnosis-aided-by-oct-octa-ocular-biomarkers 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/reflecting-on-key-takeaways-from-aao-2021-with-peter-j-mcdonnell-md 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pds-in-retinal-diseases-practical-advice-on-education-and-training 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/brolucizumab-shows-evidence-of-retinal-drying-in-wet-amd 2021-12-13 0.50 https://www.ophthalmologytimes.com/view/3d-printed-prosthetic-eye-successfully-created-by-fraunhofer-institute 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ama-supports-biden-s-newly-revealed-pandemic-strategy 2021-12-13 0.50 https://www.ophthalmologytimes.com/view/6-new-kols-welcomed-to-ocuphire-pharma-medical-advisory-board 2021-12-09 0.50 https://www.ophthalmologytimes.com/view/ces-innovation-award-given-to-heru-for-wearable-diagnostic-solution 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/unraveling-the-mystery-of-dme-outcomes 2021-12-09 0.50 https://www.ophthalmologytimes.com/view/armor-study-data-sheds-light-on-antibiotic-resistance-in-ophthalmology 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/eyecon-2021-to-cover-hot-topics-namd-gene-therapy-for-retinal-disease-sustained-drug-delivery 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pds-in-retinal-diseases-interpreting-the-ladder-and-archway-studies 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/the-development-and-safety-of-port-delivery-system-in-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/prevent-blindness-declares-first-annual-geographic-atrophy-awareness-week 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/the-inaugural-eyecon-meeting-2021-kicks-off-december-10 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/maximizing-treatment-benefits-and-unlocking-the-potential-of-proactive-extended-dosing-for-patients-with-retinal-disease 2021-12-03 0.50 https://www.ophthalmologytimes.com/view/wet-amd-home-monitoring-systems-provide-high-quality-scans 2021-12-02 0.50 https://www.ophthalmologytimes.com/view/managing-diabetic-eye-disease-eased-with-repeatable-high-quality-imaging 2021-12-15 0.50 https://www.ophthalmologytimes.com/view/fda-approves-first-biosimilar-product-for-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-examines-vr-orientation-mobility-testing-for-patients-with-inherited-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-sustained-release-anti-vegf-formula-proves-safe-and-effective-in-phase-1-trials 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/two-new-retinal-surgical-procedures-for-wet-amd-pds-and-rgx-314 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/severe-covid-19-infections-associated-with-retinal-choroidal-microvascular-lesions 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/results-from-phase-2b-study-of-ar-15512-for-the-treatment-of-dry-eye 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/prevent-blindness-national-center-for-children-s-vision-and-eye-health-forges-children-s-vision-equity-alliance 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/new-quality-measures-dashboard-from-verana-health-unveiled-at-aao 2021-11-17 0.50 https://www.ophthalmologytimes.com/view/wearable-diagnostic-platform-addresses-gaps-in-vision-care 2021-11-17 0.50 https://www.ophthalmologytimes.com/view/update-on-fda-approval-of-xipere-for-macular-edema-associated-with-uveitis-from-bausch-lomb 2021-11-16 0.50 https://www.ophthalmologytimes.com/view/aao-in-review-findings-presented-at-the-2021-annual-meeting 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/port-delivery-system-efficiently-delivers-drugs-to-retina-in-patients-with-wet-amd-study-reports 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/universal-face-masking-during-anti-vegf-injections-reduce-endophthalmitis-incidence 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sustained-retinal-stability-achieved-in-dme-with-faricimab-study-finds 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/plasma-metabolomic-profiles-linked-with-amd-progression 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/presbyopia-correcting-drops-and-their-potential-for-frustrated-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dme-changes-to-central-subfield-thickness-linked-to-worse-visual-outcomes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ocular-surface-tumors-though-rare-often-prove-deadly 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/optic-nerve-pallor-proves-prevalent-in-zika-virus-patients-study-finds 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-examines-dosing-variability-with-pre-filled-syringes-of-aflibercept-identifies-risk-of-overdose 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/bimatoprost-implant-reduces-iop-for-2-years-or-more-study-finds 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/increase-in-corneal-haze-after-corneal-crosslinking-connected-with-mitomycin-c 2021-11-09 0.50 https://www.ophthalmologytimes.com/view/intra-arterial-tissue-plasminogen-activator-beneficial-in-treatment-of-central-retinal-artery-occlusion 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/imprimisrx-president-john-saharek-discusses-3-new-products-in-the-pipeline 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/brolucizumab-deemed-noninferior-to-aflibercept-for-dme-treatment-fewer-injections-required 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/utilizing-widefield-ss-octa-to-evaluate-diabetic-retinopathy-severity 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/coed-trial-combination-steroid-and-anti-vegf-therapy-in-treatment-of-diabetic-macular-edema 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-results-are-you-planning-to-attend-the-american-academy-of-ophthalmology-meeting- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/kestrel-kite-reports-on-brolucizumab-in-treatment-of-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/combining-anterior-and-posterior-segment-surgery-5-year-follow-up-data 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-ascrs-warn-patients-about-medicare-plan-restrictions-during-open-enrollment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/iapb-announces-winners-of-world-sight-day-2021-photo-competition 2021-10-29 0.50 https://www.ophthalmologytimes.com/view/presbyopia-correcting-eye-drops-earn-fda-approval 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/tackling-teleretinal-screening-for-diabetic-retinopathy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-i-use-micropulse-laser-to-treat-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/autoimmune-disease-and-the-eye-current-thinking-and-approaches-to-treatments 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/addressing-diabetic-eye-disease-in-senior-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/oaks-and-derby-phase-3-results-efficacy-of-pegcetacoplan-in-geographic-atrophy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/covid-19-induces-macrophage-mediated-cytokine-storm-in-diabetic-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/singh-accepts-role-as-president-of-cleveland-clinic-hospitals-in-florida 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/broadening-the-benefits-of-icare-eidon-retinal-imaging-with-the-new-ultra-wide-field-module 2021-10-29 0.50 https://www.ophthalmologytimes.com/view/exploring-the-history-of-the-port-delivery-system-with-dr-carl-regillo 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-2021-welcomes-in-person-attendees-to-the-big-easy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/updates-from-asrs-2021 2022-01-05 0.50 https://www.ophthalmologytimes.com/view/prominent-cognitive-deficits-brain-fog-associated-with-covid-19 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-approves-triamcinolone-acetonide-for-suprachoroidal-injection-for-treatment-of-uveitic-macular-edema 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/genentech-s-susvimo-earns-fda-approval 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fluocinolone-acetonide-implants-in-dme-decreased-need-for-anti-vegf-supplementation 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-are-you-planning-to-attend-the-american-academy-of-ophthalmology-meeting- 2021-11-17 0.50 https://www.ophthalmologytimes.com/view/eyelet-fractures-and-scleral-sutured-iol-dislocations-study-warns-of-lens-breakage 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-approves-vr-headset-for-amblyopia-therapy-from-luminopia 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/results-of-phase-2-study-of-ar-1105-in-macular-edema-secondary-to-retinal-vein-occlusion 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/unpacking-rho-kinase-inhibition-as-a-potential-therapy-for-proliferative-vitreoretinopathy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/the-ophthalmic-experience-in-china-early-in-the-covid-19-pandemic 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/omega-therapeutics-announces-collaboration-with-stanford-university-school-of-medicine 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/panoroma-elucidates-effects-of-nonperfusion-leakage-areas-on-dme-complications-in-npdr 2021-10-18 0.50 https://www.ophthalmologytimes.com/view/celebrating-world-sight-day-2021-how-we-love-our-eyes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/eye-care-industry-takes-action-on-world-sight-day-to-preserve-vision-worldwide 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/roundup-of-findings-reported-at-asrs-39th-annual-scientific-meeting 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dissecting-real-world-registry-study-of-yutiq-for-chronic-non-infectious-posterior-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/discussing-retina-industry-insights-at-ophthalmology-innovation-summit 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-approves-dextenza-for-third-indication-ocular-itching-from-allergic-conjunctivitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/oaks-and-derby-studies-demonstrate-efficacy-of-pegcetacoplan-for-geographic-atrophy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-details-port-delivery-system-with-ranibizumab-in-namd 2021-10-06 0.50 https://www.ophthalmologytimes.com/view/commercial-oct-tracking-macrophages-in-the-macular-circulation 2021-10-06 0.50 https://www.ophthalmologytimes.com/view/higher-order-oct-analysis-for-inflammatory-signal-biomarkers-in-the-hawk-study 2021-10-06 0.50 https://www.ophthalmologytimes.com/view/masking-risk-of-endophthalmitis-after-intravitreal-anti-vegf-injections 2021-10-05 0.50 https://www.ophthalmologytimes.com/view/migs-procedures-and-endophthalmitis 2021-10-06 0.50 https://www.ophthalmologytimes.com/view/determining-the-time-to-dme-resolution-with-intravitreal-aflibercept 2021-10-06 0.50 https://www.ophthalmologytimes.com/view/faricimab-in-dme-results-from-phase-3-yosemite-and-rhine-trials 2021-10-15 0.50 https://www.ophthalmologytimes.com/view/panorama-study-outlines-variables-to-watch-when-managing-npdr 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-results-will-you-be-attending-asrs-39th-annual-scientific-meeting- 2021-10-04 0.50 https://www.ophthalmologytimes.com/view/conditional-generative-adversarial-network-assists-in-postoperative-prediction-of-oct 2021-09-21 0.50 https://www.ophthalmologytimes.com/view/fda-submits-510-k-approval-of-icare-usa-s-eidon-ultra-widefield-lens-module 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/focal-and-diffuse-dme-which-patients-are-candidates-for-micropulse- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-results-do-you-prefer-in-person-virtual-or-hybrid-ophthalmology-conferences- 2021-10-05 0.50 https://www.ophthalmologytimes.com/view/using-swept-source-oct-to-measure-macular-hole-volume 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/are-there-any-positive-takeaways-from-the-covid-19-crisis- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/untreated-dme-and-good-baseline-bcva-evaluating-risk-factors-for-vision-loss 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/virtual-reality-simulator-will-improve-access-to-vitreoretinal-surgery-training 2021-09-21 0.50 https://www.ophthalmologytimes.com/view/women-s-leadership-development-program-class-of-2021-welcomed-by-arvo 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/bid-on-bejeweled-17th-century-eyeglasses-at-sotheby-s-london 2021-09-21 0.50 https://www.ophthalmologytimes.com/view/robotic-white-cane-guides-users-to-destinations-helps-avoid-obstacles 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-has-the-pandemic-affected-you-personally-and-professionally- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/partial-visual-function-restored-in-retinitis-pigmentosa-patient-via-gene-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/what-is-encapsulated-cell-therapy- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-annual-scientific-meeting-shining-in-the-heart-of-texas 2021-09-23 0.50 https://www.ophthalmologytimes.com/view/covid-19-vaccine-s-impact-on-eyes-investigated-by-researchers 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/poll-do-you-prefer-in-person-virtual-or-hybrid-ophthalmology-conferences- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/eye-contact-is-key-to-meaningful-conversation-connection 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-can-retina-specialists-learn-from-the-covid-19-pandemic- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/researchers-develop-collision-warning-device-for-visually-impaired-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/oct-first-2d-image-by-adolf-fercher-paved-the-way-for-today-s-imaging-technique 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/euretina-2021-reviewing-this-year-s-virtual-meeting 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/study-tumor-necrosis-factor-inhibitor-reduced-anterior-chamber-inflammation 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/creating-the-best-care-environment-for-patients-with-diabetic-eye-disease 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/lightsite-ii-photobiomodulation-a-novel-therapy-for-dry-amd 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/study-better-understanding-is-key-to-beating-diabetes 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/study-targets-the-burden-of-geographic-atrophy 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/brolucizumab-injection-offers-improved-vision-in-neovascular-age-related-macular-degeneration 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/discussing-worldwide-pathological-myopia 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/managing-retinal-folds-role-of-anterior-vitreous-in-retinal-detachments 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ai-capturing-more-information-from-oct-in-neovascular-amd 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/gene-independent-therapeutic-strategies-for-retinal-degeneration-include-optogenetic-therapy 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/analyzing-classifications-of-macula-dystrophies 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/comparing-suitable-na-ve-versus-pre-treated-dme-patients 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/exploring-new-biological-treatments-in-posterior-uveitis 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/real-world-ophthalmology-a-new-conference-to-help-ophthalmologists-starting-practice 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/should-anti-vegf-agents-be-used-to-treat-patients-with-npdr- 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/facing-the-challenges-of-treating-peripheral-hemorrhagic-polypoidal-choroidal-vasculopathy 2021-09-14 0.50 https://www.ophthalmologytimes.com/view/study-targets-intravitreal-injections-for-amd-and-pcr-risks 2022-01-07 0.50 https://www.ophthalmologytimes.com/view/hurricane-ida-creates-hurdles-for-ophthalmologists-and-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/using-micropulse-to-reduce-injections-for-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/flio-provides-insight-into-autofluorescence-lifetimes-in-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ophthalmology-foundation-zeroes-in-on-mission 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/has-the-pandemic-foreshadowed-a-permanent-shift-toward-telehealth-in-ophthalmology- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/urgent-and-emergent-procedures-decreased-due-to-covid-19-is-the-change-permanent- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/gene-therapies-show-promise-as-potential-treatment-for-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/adeno-associated-virus-gene-therapy-zeroes-in-on-autoimmune-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/geographic-atrophy-a-few-things-to-help-make-sense-of-a-rapidly-changing-landscape 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/do-you-plan-to-attend-euretina-2021- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/maternal-diabetes-linked-to-high-refractive-error-in-offspring 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/have-procedures-and-patient-care-increased-since-the-covid-19-vaccine-rollout- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/the-state-of-retina-therapeutics-dissected-by-international-panel 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/optimizing-care-for-patients-with-retinal-disorders 2021-08-25 0.50 https://www.ophthalmologytimes.com/view/investigators-report-lab-grown-brain-cell-clusters-develop-primitive-eyes- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ultra-widefield-imaging-provides-visibility-of-the-posterior-segment-in-kpro-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/pfizer-biontech-covid-19-vaccine-receives-full-fda-approval 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/managing-retinal-disorders-lessons-learned-from-covid-19 2021-08-23 0.50 https://www.ophthalmologytimes.com/view/dry-amd-treatment-facilitated-by-swept-source-oct-imaging 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aao-annual-meeting-participants-required-to-provide-proof-of-covid-19-vaccination 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/asrs-provides-health-and-safety-update-for-annual-meeting 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-will-the-pandemic-affect-retina-specialists-practice-going-forward- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/port-delivery-system-with-ranibizumab-targets-namd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/future-gene-therapy-for-inherited-retinal-disease 2021-08-18 0.50 https://www.ophthalmologytimes.com/view/virtual-euretina-2021-registration-open-4-days-5-channels 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/periodic-aflibercept-injections-are-studied-in-npdr-treatment 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/sustained-release-drug-delivery-for-retinal-disorders 2021-08-16 0.50 https://www.ophthalmologytimes.com/view/combination-therapy-lowers-treatment-burden-in-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/mark-breazzano-md-addresses-patient-hesitancy-related-to-covid-19 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/dexamethasone-rebuttal-who-should-perform-intravitreal-injections- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/inner-fluid-volume-possible-independent-predictor-of-vision-after-macular-hole-repair 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/delivery-systems-in-the-pipeline-for-retinal-disorders 2021-08-10 0.50 https://www.ophthalmologytimes.com/view/study-suggests-gene-therapy-could-prevent-vision-loss-in-patients-with-retinal-disease-or-injury 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/serious-adverse-reaction-halts-gene-therapy-for-diabetic-macular-edema 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/euretina-2021-a-vast-menu-of-educational-opportunities-for-retina-specialists 2021-08-16 0.50 https://www.ophthalmologytimes.com/view/uncovering-hidden-predators-in-disease 2021-08-10 0.50 https://www.ophthalmologytimes.com/view/therapies-in-the-pipeline-for-retinal-disorders 2021-07-30 0.50 https://www.ophthalmologytimes.com/view/sustained-release-anti-inflammatory-therapy-is-valuable-in-noninfectious-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/outlook-therapeutics-reports-positive-clinical-results-for-bevacizumab-for-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/is-there-space-for-telehealth-within-retina-specialty- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/aldeyra-therapeutics-s-adx-2191-receives-orphan-drug-designation-from-fda 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/recent-treatment-advances-in-retinal-disease 2021-08-04 0.50 https://www.ophthalmologytimes.com/view/retina-specialists-may-get-ophthalmic-formulation-of-bevacizumab 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-accepts-genentech-s-bla-for-faricimab-for-treatment-of-wet-amd-and-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/drug-delivery-methods-explored-for-retinal-disease 2021-08-02 0.50 https://www.ophthalmologytimes.com/view/pediatric-ophthalmologists-target-inherited-retinal-diseases 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/encapsulated-cell-technology-delivery-of-ciliary-neurotrophic-factor-promising-treatment-for-macular-telangiectasia-type-2 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/home-monitoring-patients-for-amd-targeting-cnv 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/research-suggests-link-between-long-covid-19-and-corneal-nerve-damage 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ascrs-conference-overview-for-retina-specialists 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/addressing-drug-delivery-gaps-in-retinal-disease 2021-07-26 0.50 https://www.ophthalmologytimes.com/view/drug-delivery-challenges-in-retinal-disease 2021-07-26 0.50 https://www.ophthalmologytimes.com/view/optogenetic-gene-therapy-trial-begins-first-patient-dosed 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-has-the-covid-19-pandemic-affected-daily-practice-for-retina-specialists- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/first-signs-of-covid-19-seen-in-the-retina-investigators-report 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/gaining-a-greater-understanding-of-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/enews 2021-08-05 0.50 https://www.ophthalmologytimes.com/view/combining-sd-oct-and-uwf-improves-macular-pathology-detection 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/anti-vegf-therapy-for-retinal-disease 2021-07-19 0.50 https://www.ophthalmologytimes.com/view/inherited-retinal-disease-treatment-overview 2021-07-19 0.50 https://www.ophthalmologytimes.com/view/vegf-and-beyond-therapeutic-targeting-in-retinal-vascular-disorders 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/uv-safety-month-poll-have-you-treated-uv-related-eye-conditions-this-year- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/protecting-mitochondria-with-elamipretide 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/diabetic-macular-edema-treatment-overview 2021-07-12 0.50 https://www.ophthalmologytimes.com/view/age-related-macular-degeneration-treatment-overview 2021-07-12 0.50 https://www.ophthalmologytimes.com/view/shedding-light-on-racial-inequities-in-ophthalmology-and-ocular-healthcare 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/perfecting-the-pediatric-eye-examination 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/distinguishing-between-ms-and-neuromyelitis-optica-with-optic-neuritis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/natural-language-processing-helps-ophthalmologists-access-data-improves-data-curation 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/adaptive-optics-slo-sheds-light-on-fundus-albipunctatus 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/successful-ocular-surgery-in-patients-with-chronic-uveitis 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/elucidating-alzheimer-disease-pathophysiology 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fireworks-and-eye-injuries-how-to-stay-safe-during-independence-day-celebrations 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/evaluating-patients-for-a-retinal-disorder 2021-06-30 0.50 https://www.ophthalmologytimes.com/view/common-types-of-retinal-disorders-explored 2021-06-30 0.50 https://www.ophthalmologytimes.com/view/glaucoma-conversion-predictor-proves-faster-cheaper-than-alternatives 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fireworks-and-eye-safety-poll-which-injuries-do-ophthalmologists-see-most-often- 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ophthalmologists-may-play-a-role-in-early-alzheimer-diagnoses 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-accepts-genentech-s-bla-for-pds-with-ranibizumab-to-treat-wet-amd 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/gene-therapy-for-namd-maintains-vision-with-single-injection 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/ipl-illuminates-biomarker-for-early-stage-glaucoma 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/endogenous-endophthalmitis-management-in-patients 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/laser-imaging-system-may-offer-early-detection-treatment-of-eye-diseases-that-cause-blindness 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/outlook-is-bright-for-telemedicine-in-ophthalmology 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/measuring-intraocular-inflammation-with-standard-care-imaging 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/port-delivery-system-with-ranibizumab-proves-effective-with-consistent-administration 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/international-coalition-categorizes-25-subtypes-of-uveitis-using-machine-learning 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/lighthouse-guild-breaks-ground-on-new-assistive-technology-center-for-vision-loss-assistance 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/fda-accepts-resubmitted-xipere-nda-from-bausch-health-clearside 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/how-ophthalmology-is-pioneering-the-field-of-artificial-intelligence 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/outlook-therapeutics-approaching-fda-approval-of-bevacizumab-vikg-for-wet-amd-treatment 2021-06-02 0.50 https://www.ophthalmologytimes.com/view/ama-calls-virtual-special-meeting-gathering-june-11 2021-05-27 0.50 https://www.ophthalmologytimes.com/view/pivotal-subretinal-gene-therapy-trial-begins 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/blind-patient-achieves-partial-vision-through-gene-therapy 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/investigating-inflammation-caused-by-intravitreal-brolucizumab 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/the-posterior-segment-in-search-of-topical-treatment-options 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/eye-may-be-a-point-of-sars-cov-2-infection-study-suggests 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/retinal-leakage-and-nonperfusion-linked-with-center-involved-dme 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/treating-chronic-uveitis-with-fluocinolone-acetonide-implants 2026-06-30 0.50 https://www.ophthalmologytimes.com/view/prevent-blindness-observes-inherited-retinal-disease-genetic-testing-week-may-16-22 2026-06-30 0.50